The SPAC in an amended proxy filing today said shareholders will be asked to vote Jan. 6 for the proposed merger with Clover Health Investments. If approved, Clover is expected to receive up to $728 million of transaction proceeds, and up to $500 million of cash proceeds would be allocated to existing Clover shareholders. Read more.
Related Posts
Stock & Warrants of Blue Whale Acquisition I May Now Trade Separately
Blue Whale raised $200 million in an IPO last month, and will target one or more businesses in the media, entertainment and technology industries.
Sagaliam Acquisition Asks Shareholders for up to 10 More Months on Arabian Entertainment Deal
The transaction is expected to provide AEC up to $151.5 million.
BurTech Acquisition Raises Blaize Purchase Price, Strikes Lock-up on Convertible Notes
Blaize is a provider of AI-enabled edge computing solutions.
Investindustrial Acquisition Shareholders Approve Zegna Merger
Investindustrial last week disclosed it had secured a $125 million redemption offset to deal with any cash shortfall in its trust.